Stenting for Ischemic Strokes Secondary to Medically Refractory Intracranial Atherosclerotic Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNitin Goyal
About this trial
The goal of this observational study is to establish a prospective multicenter registry of patients undergoing intracranial stenting for ischemic strokes caused by medically refractory ICAD. The study aims to evaluate current practice patterns, periprocedural outcomes, and delayed outcomes.
Researchers will collect demographic and procedural data from patients who undergo intracranial stenting after having an ischemic stroke caused by medically refractory ICAD.
Eligibility criteria
Qualifiers
Adult patients with ICAD resulting in 70-99% vessel stenosis who undergo PTAS with any device
Patients will have to experience a stroke despite medical management involving risk factor modification and an antiplatelet agent
Baseline modified Rankin Scale (mRS) ≤ 3
Performance of the endovascular procedure at least 3 days after the last stroke
Disqualifiers
Large vessel occlusion strokes undergoing rescue intracranial stenting will not be included
Baseline modified Rankin Scale (mRS) >3
Performance of the endovascular procedure less than 3 days after the last stroke.
Patients undergoing intracranial stenting for first stroke caused by ICAD
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Semmes Murphey Clinic38120, MemphisTennessee, United States
Sponsors and collaborators
Nitin Goyal
Lead sponsor
Semmes-Murphey Foundation
Sponsor institution
Medtronic
Collaborator
Source ClinicalTrials.gov